Shingrix
The shingles vaccine, known as Shingrix, is a recombinant, non-live vaccine that helps prevent herpes zoster (shingles) and its most common complication, postherpetic neuralgia.
It is over 90% effective and recommended for adults age 50 and older, as well as adults 19+ who are immunocompromised. The vaccine is given in two doses, 2 to 6 months apart. Shingrix can cause temporary side effects like sore arm, fatigue, and fever, but offers strong and long-lasting protection.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the provided review, Shingrix is described as highly effective for shingles prevention, reducing the risk of herpes zoster and postherpetic neuralgia by over 90% in adults 50 and older. The treatment has a strong safety profile with long-lasting protection, though some short-term side effects like injection site pain and fatigue may occur.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
5.0
AI Summary of User Experiences
Not medical advice.
Based on the provided review, Shingrix is described as highly effective for shingles prevention, reducing the risk of herpes zoster and postherpetic neuralgia by over 90% in adults 50 and older. The treatment has a strong safety profile with long-lasting protection, though some short-term side effects like injection site pain and fatigue may occur.
Reviews
Filter by reviewer type Pro